Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Clinical Neurology and Neurosurgery|December 11, 2013
Management of fingolimod in clinical practiceKatja Thomas, Tjalf ZiemssenTherapeutic Advances in Neurological Disorders|October 3, 2017
Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real worldTjalf Ziemssen, Katja ThomasBMC Neurology|August 4, 2016
Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approachTjalf Ziemssen, Raimar Kern, Katja ThomasExpert Opinion on Drug Metabolism & Toxicology|April 20, 2016
Laquinimod in the treatment of relapsing remitting multiple sclerosisUndine Hainke, Katja Thomas, Tjalf ZiemssenExpert Opinion on Pharmacotherapy|August 29, 2017
Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosisKatja Thomas, Undine Proschmann, Tjalf ZiemssenNeurology|July 30, 2013
Neuroborreliosis during natalizumab treatment in multiple sclerosisKatja Thomas, Thorsten Schultheiss, Tjalf ZiemssenBMC Neurology|June 8, 2014
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery diseaseKatja Thomas, Hagen Schrötter, Michael Halank, et al.Parasitology Research|February 25, 2009
The parasite fauna of stray domestic cats (Felis catus) in Dubai, United Arab EmiratesRolf K Schuster, Katja Thomas, Saritha Sivakumar, et al.Journal of Medical Internet Research|October 17, 2012
Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire studyRocco Haase, Thorsten Schultheiss, Raimar Kempcke, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2017
Natalizumab during pregnancy and lactationUndine Proschmann, Katja Thomas, Sandra Thiel, et al.Pageof 2